In vivo treatment with insulin-like growth factor 1 reduces CCR5 expression on vaccine-induced activated CD4+ T-cells
Creators
- 1. Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, Maryland, USA
Description
Dataset of the publication "In vivo treatment with insulin-like growth factor 1 reduces CCR5 expression on vaccine-induced activated CD4+ T-cells" by Bissa et al. on the journal Vaccines.
Each folder contains the original files reporting the data used to generate the manuscript.
For flowcytometry based assays the Flow panel is included in the folders.
For ELISA based assays the schemes of the plates are included in the folders.
The excel table "Bissa et al._Vaccines_2023_Animal IDs and viral acquisition" reports the IDs and grouping of the animals together with their viral acquisition
The excel table "Bissa et al._Vaccines_2023_Master table" reports each data used to generate the figures and supplemental materials included in the publication
Files
293T cells Transfection_Free IGF-1 ELISA.zip
Files
(4.6 GB)
Name | Size | Download all |
---|---|---|
md5:a7f368bf6cf3e89dfdd5da8e7b290799
|
17.3 kB | Preview Download |
md5:8ce7ec0ddc4cac352c03885be6e343e7
|
764.9 kB | Preview Download |
md5:08771e3e112a57a74c5c6144bbcc772e
|
179.5 kB | Preview Download |
md5:2c48b644bb94376e1ccd0d3877898aac
|
10.5 kB | Download |
md5:55d610557aa35cefe6f7b94d2da77ca6
|
82.0 kB | Download |
md5:e2b59315d4416ebfb123a54e0c14f892
|
246.5 kB | Preview Download |
md5:8f9d3ded2cd09b255a1398e269f695ab
|
661.9 MB | Preview Download |
md5:4872952430780c4fb4c40dcebb958b01
|
29.2 kB | Preview Download |
md5:135bed1c00dc35ba0489014ecc6db1d1
|
24.5 kB | Preview Download |
md5:6d9b882d037af895ab1cff448b291702
|
33.0 kB | Preview Download |
md5:ade36f5afaecffb07ae69bda0cb08223
|
281.2 MB | Preview Download |
md5:101fe67c4394d1045537e59cd5bd4e8b
|
142.2 kB | Preview Download |
md5:6b539700218b9cf05c2b4bb5aa8e98b0
|
652.1 MB | Preview Download |
md5:0089259c16b88f9417fe53789948ec5c
|
16.9 kB | Preview Download |
md5:675a0a0d4972fd710a68c355bc723015
|
24.6 kB | Preview Download |
md5:0a3ea9319e25a36318c668e268d09dda
|
19.0 kB | Preview Download |
md5:106e5abdf1fc62f78ccf95d111432f38
|
1.1 GB | Preview Download |
md5:ad839ca5777e62aa3f2b90fc6bd58685
|
20.5 kB | Preview Download |
md5:73e126af14f067e83670d4215f60345f
|
129.2 kB | Preview Download |
md5:aa159b7e13a61bc44997c2b041faf869
|
25.4 kB | Preview Download |
md5:a65594d2f944a442517fa420d0013a99
|
41.4 kB | Preview Download |
md5:7b6b10f5af12688abaef6aac175cd0cb
|
1.5 GB | Preview Download |
md5:fd78eef12ac510c27c0b1b0b04a3bd93
|
676.7 kB | Preview Download |
md5:3f06835fa9d7c14f661c982017cf6089
|
100.7 kB | Preview Download |
md5:3948b1f0ff6cfd61c7aa958c93fddaf7
|
139.4 kB | Preview Download |
md5:7cfe8b687676ca7f3fed3ce7c5d5bfd8
|
25.8 kB | Preview Download |
md5:537445521637999bbcd1c55b98d30fd5
|
421.1 MB | Preview Download |
Additional details
Related works
- Is published in
- Publication: 10.3390/vaccines11111662 (DOI)